Skip to main content

Manufacturing and batch records

What pressure differential, air change rate and clean-up time does a GMP cleanroom need?

EU GMP Annex 1 gives guidance values of at least 10 Pa between rooms of different grades, a clean-up time under 20 minutes and unidirectional airflow of 0.36 to 0.54 m/s. It sets no air change rate. FDA’s 2004 aseptic guidance suggests at least 10 to 15 Pa (0.04 to 0.06 inches of water) and calls at least 20 air changes per hour typically acceptable for ISO 8 support rooms. None is a legal limit; you justify yours in qualification.

Illustration of a seal beside a production line of sealed vials.

1The numbers, and how binding each one is.

Table 1. Annex 1, 2022;¹ FDA, 2004;² WHO, 2018 and 2019.³⁴ Inches of water gauge in brackets, at 1 in. ≈ 249 Pa, matching FDA’s own footnotes.
ParameterEU GMP Annex 1FDA aseptic guidanceWHO, non-sterile
Between gradesAt least 10 Pa (0.04 in.)At least 10 to 15 Pa (0.04 to 0.06 in.), doors closed5 to 20 Pa (0.02 to 0.08 in.)
To a lower gradePositive pressure and/or airflow, in all conditionsAt least 12.5 Pa (0.05 in.) to an unclassified room, “at all times”Dusty rooms: corridor highest, rooms above atmosphere
Isolator to roomNo figureHas “largely ranged” from 17.5 to 50 Pa (0.07 to 0.20 in.)Not covered
Air changes per hourNo figureAt least 20 for ISO 8; “significantly higher” for ISO 7 and ISO 56 to 20
Clean-up timeUnder 20 minutesNo figureAbout 15 to 20 minutes
UDAF air speed0.36 to 0.54 m/s at the working position0.45 m/s ±20%, the same rangeNo figure
MonitoringCritical ones continuous, recorded and alarmedContinuous each shift, frequently recordedGauges or EMS/BMS, alarms with justified dead times

For a GMP manufacturer, none of these numbers is a legal limit.

  • The US regulations set no figure. Aseptic processing needs HEPA-filtered air “under positive pressure”, and equipment for “adequate control over air pressure” when appropriate.⁵⁶ FDA’s guidance is labelled “Contains Nonbinding Recommendations” and offers its 10 to 15 Pa and 12.5 Pa figures as examples.²
  • Annex 1 calls its three numbers guidance values. It gives 10 Pa, 20 minutes and 0.36 to 0.54 m/s each as a “guidance value”, and for air speed adds “unless otherwise scientifically justified in the CCS”.¹ PIC/S PI 058-1, in force since 28 October 2026, accepts other speeds justified in the CCS, for powders where the range itself risks contamination and for barrier systems whose airflow studies show first air protection.⁷
  • The UK and PIC/S use the same annex. MHRA points manufacturers to EudraLex Volume 4, which holds it,⁸ and PIC/S, the EU and WHO agreed to interpret it the same way.⁷
  • Non-sterile EU sites get no figure. The EU GMP guide asks for production areas to be “effectively ventilated”, and lists “appropriate use of air-locks and pressure cascade” among measures against cross-contamination.⁹¹⁰ For a number, WHO recommends a minimum of 5 Pa for containment.⁴
  • Containment can reverse the cascade. For pathogenic, highly toxic, radioactive or live viral or bacterial materials, Annex 1 allows positively or negatively pressurised airlocks, but air that must flow into a critical zone should come from the same or a higher grade.¹
  • Pharmacies compounding under section 503A follow USP <797> instead. Section 503A exempts their drugs from CGMP on conditions that include compounding to USP’s chapters, which states, not USP, enforce.¹¹¹² See 503A vs 503B.

1.1Air changes per hour for ISO 8, ISO 7 and ISO 5.

Air changes per hour is the air supplied to a room in m³ per hour divided by the room volume in m³.³ Only FDA’s guidance ties a figure to a cleanroom class: at least 20 for ISO 8 support rooms is “typically acceptable”, and “significantly higher” rates are normally needed for ISO 7 and ISO 5, with no number.² Annex 1 never uses the term; it judges the air supply by classification, clean-up time and airflow studies.¹ Any per-class range you find for ISO 7 or ISO 5 is a design rule of thumb, not a requirement. ISO 14644-1 defines its classes by particle concentration, not airflow.¹³

Sizing it from the room. A textbook estimate, not a regulatory method: with perfect mixing and clean supply air, a room settles where concentration equals particle emission ÷ supply air, so supply air = emission ÷ target concentration. ISO 14644-4:2022 recommends using the air supply rate to calculate contaminant dilution, and calls the rate at which a person, machine or object emits particles its source strength.¹⁴ Example, invented: a 90 m³ ISO 7 room whose operators and filling machine are estimated to emit 288 million particles ≥0.5 µm an hour. To hold 80,000 per m³, under a quarter of the 352,000 limit to allow for imperfect mixing and busy moments,² it needs 288,000,000 ÷ 80,000 = 3,600 m³/h, or 40 air changes an hour. Halve the emission with better gowning or fewer people and half the air holds the same level. Then prove the figure by classification in operation and a measured clean-up time.¹

Under unidirectional airflow the measure is air speed: 0.45 m/s from a full filter ceiling 3 m high supplies 540 air changes an hour (0.45 × 3,600 ÷ 3), so an ISO 5 air change figure only restates the speed.

2Example: a cascade and air change check for a filling suite.

The suite and every figure below are invented. The filling line runs in a RABS, so its background should be at least grade B, and the final stage of an airlock takes the grade of the room it leads into.¹

Table 2. Example. Pressure cascade, doors closed.¹²
RoomGradeSet point vs corridorStep to next room outCheck
FillingB+55 Pa10 Pa to airlockSame grade: no figure, but FDA says a difference “can provide beneficial separation”
AirlockB+45 Pa15 Pa to preparationDifferent grades: above 10 Pa
PreparationC+30 Pa15 Pa to washAbove 10 Pa
WashD+15 Pa15 Pa to corridorPositive to the unclassified area
CorridorUnclassified0 PaNoneCommon reference point

2.1The alarm-band trap.

Suppose each room alarms only on its own pressure against the corridor, at ±5 Pa from its set point. The airlock can read 40 Pa and preparation 35 Pa with no alarm: a 5 Pa step. If each transmitter is accurate to ±1 Pa, the true step could be 3 Pa. That passes WHO’s minimum test, that cumulative instrument tolerances “should not cause a situation where an undetected reversal of airflow is possible”.⁴ It still lets the step fall far below Annex 1’s 10 Pa guidance value unseen.¹

2.2Across each door or to a common reference.

Annex 1 wants pressure indicators “fitted between cleanrooms”, which can be wired two ways.¹

  • Across each door. One transmitter reads the step that protects the door, with one instrument’s tolerance.
  • To a common reference. Every room is read against one point, such as the corridor, which WHO names as one way to keep cumulative tolerances from hiding a reversal.⁴ A step between two rooms is then the difference of two readings and carries both tolerances, so alarm on that calculated step, or the trap above returns.

Either way, WHO asks for room pressure to be traced back to ambient “by summation of the room pressure differentials”, and for gauges whose range and graduation can be read to an appropriate accuracy.³ Choose a range that runs below zero, such as −10 to +30 Pa for a 15 Pa step, so a reversal is recorded as a negative value rather than clipped at zero. The suite measures across each door, with transmitters accurate to ±1 Pa.

Table 3. Example. An action level of 11 Pa read by a ±1 Pa transmitter keeps the true step at 10 Pa or more.
DifferentialAlertActionDelayBasis for the delay
Airlock to preparationBelow 13 PaBelow 11 Pa45 sDoor cycles took up to 15 s in qualification and the step recovered within 20 s of closing, plus 10 s
Preparation to washBelow 13 PaBelow 11 Pa75 sTrolley transfers held the door up to 40 s; recovery within 25 s, plus 10 s
Wash to corridorBelow 13 PaBelow 11 Pa45 sPersonnel door; same data as the airlock
Filling to airlockBelow 7 PaBelow 4 Pa45 sSame grade; set from qualification data

Annex 1 wants any alarm delay “assessed and justified within the CCS”; WHO likewise wants “justified dead times”.¹³ FDA calls it critical that “the time a door can remain ajar be strictly controlled”, so separate door-open alarms sound after 20 seconds on personnel doors and 45 seconds on the trolley door.²

2.3Air changes and clean-up time.

On the same textbook model, particle concentration falls by a factor R in ln(R) ÷ N hours, where N is the air change rate. The factor comes from Annex 1 Table 1, set out in cleanroom grades: grade B should fall from its in-operation limit of 352,000 particles ≥0.5 µm/m³ to its at-rest limit of 3,520, a factor of 100; grade C from 3,520,000 to 352,000, a factor of 10.¹

Table 4. Example. Annex 1 leaves grade D’s in-operation limit to the manufacturer, from risk assessment and routine data.¹
RoomVolume and supplyAir changesFactorEstimateMeasured
Filling (B)144 m³; 5,760 m³/h40 per hour100ln(100) ÷ 40 h = 6.9 min12 min
Preparation (C)90 m³; 2,700 m³/h30 per hour10ln(10) ÷ 30 h = 4.6 min9 min
Wash (D)60 m³; 1,200 m³/h20 per hourSite-setNot calculatedRecovery tested

Both measured times beat the 20-minute guidance value and run longer than the estimates, because no real room mixes perfectly. The measured period goes into the procedure that restores the rooms after a disruption, as Annex 1 4.29 asks.¹

3Records an inspector will ask for.

Table 5. Checklist. Pharmathen’s warning letter, below, shows what follows when the trend data and alarm history do not exist.
RecordWhat it must showRequirement
Cascade drawingRooms, grades, set points and flow direction; alert and action limits displayed at the gauge or EMSAnnex 1 4.16; WHO TRS 1010 7.7¹³
CCS entryWhich differentials are critical, and why each alarm delay is safeAnnex 1 4.16¹
Trend dataRetained continuous records of critical differentials; others at set intervalsAnnex 1 4.16; FDA IV.C¹²
Alarm historyEvery alarm, its assessment and response, and a trend reviewAnnex 1 4.16 and 5.2; FDA IV.C¹²
Calibration recordsTransmitter calibration, and zero checks at set intervalsWHO TRS 1010 7.8 and 7.10³
Door controlsInterlock or warning tests, and door-open time limitsAnnex 1 4.13; FDA IV.C¹²
Requalification reportPressure verification and the other minimum tests, on timeAnnex 1 4.32¹
Airflow studiesVideo that agrees with the air speed measurementsAnnex 1 4.15 and 4.30¹
Clean-up and restartThe qualified clean-up period; how a room is restored after a disruption or an air handling shutdownAnnex 1 4.29; FDA IV.E¹²

4When a pressure alarm sounds.

  1. Acknowledge and record it. Annex 1 says the warning “should not be overridden without assessment”; FDA says all alarms should be documented and deviations from established limits investigated.¹²
  2. Read the trace, not only the alarm. How low the differential fell, whether it reversed and for how long, against the delay you justified.
  3. Find the cause. A held door, a failed interlock, a machine extract starting, a transient WHO tells designers to allow for, or a faltering air handling unit.³
  4. Assess the exposure. Was product or sterile equipment open in grade A? Check particle counts and viable results near the door for that window, against the critical differences your CCS names.¹
  5. Restore and confirm. When an aseptic room’s overpressure to an unclassified neighbour falls below its minimum, FDA says its environmental quality should be “restored and confirmed”; Annex 1 points to the clean-up period you qualified.²¹
  6. Escalate by rule. An action-level breach or a reversal into a higher grade opens a deviation.
  7. Trend the alarms. Annex 1 asks for alarm events to be evaluated for trends, with critical alarms reviewed immediately.¹ A door that trips every shift needs a design or procedure fix, not a longer delay.

If the air stops. Annex 1 also wants a warning of “any failure in the air supply”, and lists an interruption of air movement among the changes that can call for requalification.¹ FDA wants deviation or change control to cover air handling shutdowns and a written procedure for returning to operating conditions, and says “Any disruption in power supply, however momentary, that could affect product quality is a manufacturing deviation and must be included in batch records”.² Record when the air stopped and restarted, what was open, the decision on product in process and on breaking down the line, and the cleaning, clean-up period and monitoring before restart. Keep the monitoring system recording through the outage, or there is nothing to assess.

5What qualification and requalification test.

Qualification includes airflow volume and velocity, the pressure difference, airflow visualisation and a recovery test, referenced to ISO 14644.¹ Requalification, at least every 6 months for grades A and B and every 12 for C and D, needs at least five tests: classification, final filter integrity, airflow volume, the pressure difference between rooms, and air velocity, which a recovery test replaces where airflow is not unidirectional.¹ Measure air speed “at the working position”, justify the location in the protocol, and make the airflow visualisation agree with it; see smoke studies.¹

6What inspectors cite.

FDA’s letter to a Greek sterile manufacturer named both an inadequate cascade and the missing record:

“Furthermore, you failed to routinely record basic facility monitoring data, including differential pressure, temperature, and humidity. Your monitoring devices displayed real-time data only and lack data storage capability. As a result, parameter excursions that occur when operators are not actively monitoring pressures went undocumented. You also had no alarm history or recorded data.” Pharmathen International S.A., warning letter, 27 May 2026¹⁵

The same letter found the aseptic filling rooms “had lower pressure than the adjacent rooms”.¹⁵ A Form 483 issued in August 2026 to a Texas producer of sterile drugs recorded, as its second observation:

“A pattern of frequent or acute pressure reversals was observed from areas of less clean air to areas of higher air cleanliness.” Houston Rx LLC, Form FDA 483, 28 August 2026¹⁶

Its records showed every reading for six weeks below zero between the ISO 7 buffer room and the ISO 8 ante room, and every lot made in that time had been released.¹⁶ FDA’s 2020 guidance on insanitary conditions at compounding facilities lists that pattern among conditions so serious that it “strongly recommends” an immediate recall of purportedly sterile drugs and a halt to sterile operations.¹⁷

European inspectors cite the same failure. Portugal’s medicines authority found this at an Indian maker of sterile cephalosporin powder for injection:

“Critical failures were observed in facility design and pressure cascade maintenance, including inadequate differential pressures between classified and non classified areas, reversed pressure gradients, and layout constraints that resulted in sterile API being exposed in Grade B.” Ananta Medicare Limited, statement of non-compliance FT094/MH/001/2024/NCR, EudraGMDP, 6 August 2026¹⁸

7How it runs in Seal.

In Seal, the contamination control strategy connects rooms, grades, pressure cascades and personnel and material flows to approved layouts, qualification and routine monitoring, so a door alarm or a pressure failure identifies which risks and product-exposure windows need assessment. Pressure instability can be combined with other signals, such as repeated low recoveries or a flora shift, into one CCS signal, and a room or HVAC change cannot close until the affected CCS links and narrative are reviewed.

In commissioning and qualification, an air handler is qualified together with its rooms, controls, alarms, sensors and monitoring, and a critical alarm challenge records the stimulus, the expected alarm and the response.

References

  1. 1EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products, C(2022) 5938 final, European Commission, 22 August 2022, in operation since 25 August 2023, paragraphs 4.12 to 4.16, 4.20, 4.25, 4.29, 4.30, 4.32, 5.2 and Table 1. https://health.ec.europa.eu/system/files/2022-08/20220825_gmp-an1_en_0.pdf (read 8 November 2026)
  2. 2Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice, FDA, September 2004, Table 1, sections IV.A, IV.C with footnotes 5 and 6, IV.E and XII, and Appendix 1 with footnote 22. https://www.fda.gov/media/71026/download (read 8 November 2026)
  3. 3Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products, WHO Technical Report Series No. 1010, Annex 8, World Health Organization, 2018, glossary and sections 5 and 7.7 to 7.11. https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/trs1010-annex8-who-gmp-heating-ventilation-airconditioning.pdf (read 8 November 2026)
  4. 4Guidelines on heating, ventilation and air-conditioning systems for non-sterile pharmaceutical products, Part 2: Interpretation, WHO Technical Report Series No. 1019, Annex 2, World Health Organization, 2019, sections 5.1 and 7. https://cdn.who.int/media/docs/default-source/medicines/norms-and-standards/guidelines/production/who-good-manufacturing-practices-for-heating-ventilation-and-air-conditioning-systems-for-non-sterile-pharmaceutical-products-(part-2)-interpretation-of-guidelines.pdf (read 8 November 2026)
  5. 521 CFR 211.42, Design and construction features, paragraph (c)(10)(iii), eCFR. https://www.ecfr.gov/current/title-21/section-211.42 (read 8 November 2026)
  6. 621 CFR 211.46, Ventilation, air filtration, air heating and cooling, paragraph (b), eCFR. https://www.ecfr.gov/current/title-21/section-211.46 (read 8 November 2026)
  7. 7PI 058-1, Interpretation of the Most Important Changes in the Annex 1 on the Manufacture of Sterile Products (2022), section 1 and questions 4.19 and 4.30, PIC/S, in force 28 October 2026. https://picscheme.org/docview/11495 (read 8 November 2026)
  8. 8Medicines: good manufacturing practice and good distribution practice, MHRA, GOV.UK. https://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practice (read 8 November 2026)
  9. 9EudraLex Volume 4, Part I, Chapter 3: Premises and Equipment, paragraph 3.12, European Commission, in operation since 1 March 2015. https://health.ec.europa.eu/document/download/18d76565-137b-41d2-a602-794527f708c1_en?filename=chapter_3.pdf (read 8 November 2026)
  10. 10EudraLex Volume 4, Part I, Chapter 5: Production, paragraph 5.21(x), European Commission, in operation since 1 March 2015. https://health.ec.europa.eu/document/download/4a1fdb4f-6f6f-49c4-b264-8056e5bbe078_en?filename=chapter_5.pdf (read 8 November 2026)
  11. 11Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act, guidance, Revision 2, FDA, June 2016, section III.A and footnote 8. https://www.fda.gov/media/94393/download (read 8 November 2026)
  12. 12USP General Chapter <797> FAQs, questions 7 and 8, United States Pharmacopeia, updated 11 December 2023. https://pages.usp.org/rs/711-SXF-172/images/USP_HQS_797_FAQs_December2023_V6__002.pdf (read 8 November 2026)
  13. 13ISO 14644-1:2015, Cleanrooms and associated controlled environments, Part 1: Classification of air cleanliness by particle concentration, abstract, ISO. https://www.iso.org/standard/53394.html (read 8 November 2026)
  14. 14ISO 14644-4:2022, Cleanrooms and associated controlled environments, Part 4: Design, construction and start-up, introduction, item (f), and clause 3.1.13, in ISO’s Online Browsing Platform preview. https://www.iso.org/obp/ui/en/#iso:std:iso:14644:-4:ed-2:v1:en (read 8 November 2026)
  15. 15Pharmathen International S.A., warning letter, MARCS-CMS 723680, FDA, 27 May 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmathen-international-sa-723680-05272026 (read 8 November 2026)
  16. 16Houston Rx LLC, Houston, Texas, Form FDA 483, issued 28 August 2026, observation 2. https://www.fda.gov/media/195122/download (read 8 November 2026)
  17. 17Insanitary Conditions at Compounding Facilities, guidance for industry, FDA, November 2020, sections III.A and III.B. https://www.fda.gov/media/124948/download (read 8 November 2026)
  18. 18Statement of non-compliance with GMP, report FT094/MH/001/2024/NCR, Ananta Medicare Limited, Sri Ganganagar, India, National Authority of Medicines and Health Products (Portugal), issued 6 August 2026 after an inspection ending 9 July 2026, EudraGMDP (search non-compliance reports by issue date). https://eudragmdp.ema.europa.eu/inspections/gmpc/searchGMPNonCompliance.do (read 8 November 2026)

AQuestions and answers

Can a cleanroom pressure differential be too high?

Yes. WHO’s interpretation of its HVAC guideline says a differential should be large enough to prevent flow reversal but not so high that it creates turbulence problems, and suggests 5 to 20 Pa between non-sterile rooms. Annex 1 gives only a minimum, so set an upper limit as well: WHO expects manufacturers to define both the upper and the lower limit for each differential.

What is the difference between clean-up time and recovery time?

Annex 1’s clean-up period is operational: once real operations and line clearance end, the unmanned room must fall from its in-operation state back within its at-rest particle limits, with a guidance value under 20 minutes, and the qualified period is written into procedures. A recovery test is a qualification test: the room is briefly challenged with an artificial particle source and timed back to a specified level. WHO uses both names for the same capability, which is why they get confused. When grades without unidirectional airflow are requalified, Annex 1 has a recovery test replace the air velocity test.

What is the difference between a cascade, sink and bubble airlock?

WHO names three. A cascade airlock sits between the pressures of the rooms either side, so air moves one way through it, and the difference between the two outer rooms usually matters more than the airlock’s own pressure. A sink airlock is lower than both sides, so air flows into it from each, and a bubble airlock is higher than both, so air flows out into each. Annex 1 allows positively or negatively pressurised airlocks where hazardous material has to be kept from the surrounding areas.

How often should cleanroom pressure transmitters be calibrated?

Neither Annex 1, FDA’s aseptic guidance nor WHO’s HVAC guideline sets an interval. WHO asks for pressure control and monitoring devices to be calibrated, for compliance with specifications to be verified regularly and recorded, and for zero settings to be tamper-proof and checked at regular intervals. The interval is yours to justify from how critical the differential is and how far each device has drifted between calibrations.

See your process in Seal.

Bring a procedure or a recurring problem. See how your team configures it with Neil and improves the next run.

Book a demo